Decision Diagnostics Corp. (DECN) is pioneering a novel glucose test strip tailored for diabetics and pets. With CFO Keith Berman's guidance, the company is dedicated to diagnostic advancements. Explore DECN's cutting-edge technology and its impact on healthcare for both humans and animals. Stay tuned for updates on this exciting development.